ERCC 1/BRCA1 protein expressions and ERCC1/XPD/XRCC1-3 gene polymorphisms as predictor factors of outcome in stage III-IV non-small cell lung cancer (NSCLC) patients treated in first-line chemotherapy with or without cisplatin